26 Programs

  • What Clinicians Want to Know: Optimizing the Management of Metastatic Triple-Negative Breast Cancer

    Explore program
  • Consensus or Controversy? Clinical Investigators Discuss and Debate Current Approaches to First- and Second-Line Therapy for HR-Positive Metastatic Breast Cancer

    Explore program
  • What Clinicians Want to Know: First-Line and Maintenance Therapy for Patients with ER-Positive HER2-Positive Metastatic Breast Cancer

    Explore program
  • Practical Perspectives on the Current and Future Management of Immune Thrombocytopenia — What Happened at ASH 2025?

    Explore program